(GL) Globe Life - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37959E1029
GL EPS (Earnings per Share)
GL Revenue
GL: Life Insurance, Supplemental Health Insurance, Annuities
Globe Life Inc. is a leading provider of life and supplemental health insurance products, as well as annuities, catering to lower middle- and middle-income families in the United States. The companys diversified product portfolio includes whole, term, and other life insurance products, alongside Medicare supplement and limited-benefit supplemental health insurance products. Globe Life Inc.s distribution channels comprise a direct-to-consumer division, exclusive agencies, and independent agents, allowing it to effectively reach its target market.
The companys operational structure is segmented into Life Insurance, Supplemental Health Insurance, and Investments, enabling a focused approach to managing its diverse product offerings. With a rich history dating back to 1900, Globe Life Inc. has established itself as a reputable player in the insurance industry. The companys rebranding from Torchmark Corporation to Globe Life Inc. in August 2019 marked a significant milestone in its evolution.
Analyzing the
Based on the
Additional Sources for GL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
GL Stock Overview
Market Cap in USD | 9,957m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1987-12-30 |
GL Stock Ratings
Growth Rating | 62.2 |
Fundamental | 61.2 |
Dividend Rating | 56.0 |
Rel. Strength | 18 |
Analysts | 3.9 of 5 |
Fair Price Momentum | 129.65 USD |
Fair Price DCF | 330.05 USD |
GL Dividends
Dividend Yield 12m | 1.07% |
Yield on Cost 5y | 1.82% |
Annual Growth 5y | 5.10% |
Payout Consistency | 89.7% |
Payout Ratio | 8.1% |
GL Growth Ratios
Growth Correlation 3m | -15.6% |
Growth Correlation 12m | 87.1% |
Growth Correlation 5y | 65.6% |
CAGR 5y | 12.30% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 2.78 |
Alpha | 40.57 |
Beta | 0.748 |
Volatility | 20.96% |
Current Volume | 652.1k |
Average Volume 20d | 486.3k |
As of July 01, 2025, the stock is trading at USD 123.89 with a total of 652,075 shares traded.
Over the past week, the price has changed by +1.46%, over one month by +2.41%, over three months by -5.75% and over the past year by +50.98%.
Yes, based on ValueRay´s Fundamental Analyses, Globe Life (NYSE:GL) is currently (July 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.22 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GL is around 129.65 USD . This means that GL is currently overvalued and has a potential downside of 4.65%.
Globe Life has received a consensus analysts rating of 3.90. Therefor, it is recommend to buy GL.
- Strong Buy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, GL Globe Life will be worth about 144.2 in July 2026. The stock is currently trading at 123.89. This means that the stock has a potential upside of +16.39%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 144.6 | 16.7% |
Analysts Target Price | 142.4 | 14.9% |
ValueRay Target Price | 144.2 | 16.4% |